ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Tatva Chintan Pharma Chem Limited submitted its annual disclosure for FY 2025-26, confirming it does not meet the criteria for classification as a 'Large Corporate' under SEBI debt-raising norms. The company reported nil incremental borrowing and mandatory debt issuance requirements for the current block.
Tatva Chintan Pharma Chem Limited confirmed it is not classified as a Large Corporate under SEBI debt-raising norms. As of March 31, 2026, the company reported outstanding borrowings of ₹6.04 Crore. The company maintains a long-term credit rating of CRISIL BBB+/Stable and a short-term rating of CRISIL A2.